Table 1 Countries and governing instruments issued to streamline COVID-19 research ethics review
Country | Governing instrument | Issuing authority |
|---|---|---|
Argentina | Resolution 908/2020, Ethical and operational guidelines for accelerated ethics review of COVID-19-related human research (May 2020) | Ministry of Health |
Communication ANMAT (May 2020) | ANMAT (NRA*) | |
Brazil | GUIDELINES FOR CONDUCTING RESEARCH AND REC ACTIVITY DURING THE PANDEMIC CAUSED BY CORONAVIRUS SARS-COV-2 | National Research Ethics Commission—CONEP |
Technical Note 23/2020 (July 2020) | ANVISA (NRA) | |
Chile | Recommendations for scientific ethics committees for research protocols review in the context of the COVID-19 pandemic (June, 2020) | Ministerial Health Research Ethics Commission- CMEIS |
Colombia | External Circular 1000–174-20 (July 2020) | INVIMA (NRA) |
Costa Rica | Communique 1: Specific considerations for biomedical research in the context of the pandemic (April, 2020) | National Health Research Council—CONIS |
Communique 2: Recommendations for the conduct of biomedical research during the health emergency in Costa Rica (August, 2020) | ||
Manual of procedures to streamline scientific and ethics review and oversight of COVID-19-related biomedical research (July, 2020) | Social Security Administration—CCSS | |
Dominican Republic | Communique, The CONABIOS in times of COVID-19 (April, 2020) | National Council of Bioethics in Health—CONABIOS |
Ecuador | Ministerial Agreement No 0003, Regulation for health research during the health emergency (April, 2020) repealed through the Ministerial Agreement No 00,104, Regulation for the approval and the conduct of health research related to COVID-19 (December, 2020) | Ministry of Health |
Mexico | Bioethics in the face of the COVID-19 pandemic (March 2020) | National Commission on Bioethics—CONBIOETICA |
Communique No 007 COVID-19 (May 2020) | COFEPRIS (NRA) | |
Communication “Extraordinary Measures in relation to Clinical trials during the pandemic” (April 2020) | ||
Panama | Resolution No 373 (13 April 2020) | Ministry of Health |
Peru | Supreme Decree No 014–2020-SA that establishes measures for the adequate conduct of COVID-19 clinical trials in the context of the health emergency (April, 2020) | Ministry of Health |
PNIH Chief Resolution No 096–2020-J-OPE/INS that creates the National Transitory Research Ethics Committee for the ethics review and oversight of COVID-19 clinical trials (April, 2020) | Peruvian National Institute of Health (PNIH) | |
PNIH Chief Resolution No 097–2020-J-OPE/INS that approves the procedure for the ethics review of COVID-19 clinical trials (April, 2020) | ||
PNIH Chief Resolution No 139–2020-J-OPE/INS that approves guidelines for the conduct of clinical trials during the COVID-19 pandemic (June, 2020) | ||
Directorial Resolution No 120–2020-OGITT/INS that approves the NTREC-COVID19 operating procedures (April, 2020) |